Wolfe Research Affirms ‘Outperform’ Stance on UnitedHealth Group (UNH) Amid Medical Billing Pressures

UnitedHealth Group Incorporated (NYSE:UNH) is one of Goldman Sachs’ top healthcare stock picks. On July 10, Wolfe Research reiterated an ‘Outperform’ rating on the stock. However, the research firm lowered its price target to $330 from $363, citing the medical billing pressures the company is facing.

Wolfe Research Affirms ‘Outperform’ Stance on UnitedHealth Group (UNH) Amid Medical Billing Pressures

A hospital technician using a laptop to review health benefit plans of a patient in the ward.

The research firm has since revised the company’s 2025 earnings estimate to $18. The revision underscores a more conservative view as UnitedHealth faces industry pressures in Medicaid and health insurance exchanges. The research firm views Optum Health and Medicare Advantage as units facing significant earnings pressure.

According to Wolfe Research, UnitedHealth is generating 1% margins in Mediocre Advantage, which is below its long-term margins. The company is expected to update its 2025 earnings guidance and shed light on its earnings trajectory amid the pressures from medical insurance billing.

UnitedHealth Group Incorporated (NYSE:UNH) is a healthcare company that offers consumer-oriented health benefit plans and services. It also provides care delivery, care management, wellness, and consumer engagement, as well as health financial services to patients.

While we acknowledge the potential of UNH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 11 Best Green Energy Penny Stocks to Buy Right Now and 10 Most Popular AI Penny Stocks to Buy According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.